Last $40.50 USD
Change Today +1.70 / 4.38%
Volume 135.2K
XLRN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas P. Maniatis Ph.D.

Co-Founder, Chairman of Scientific Advisory Board, Director and Member of Compensation Committee, Acceleron Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 31 board members in 3 different organizations across 5 different industries.

See Board Relationships
71$333,441

Background*

Dr. Thomas P. Maniatis, also known as Tom, Ph.D is a Science Partner of The Column Group LLC. He was previously the Member of Advisory Board at the firm. Dr. Maniatis is also a Co-founder, and has been Member of the Board of Directors and the Head of the Scientific Advisory Board of Acceleron Pharma Inc. since 2003. He is a Professor of Biochemistry and Molecular and Cellular Biology at Harvard University since 1981. Dr. Maniatis is Professor and Chairman of the Department ...

Read Full Background

Corporate Headquarters*

128 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-649-9200
Fax: 617-649-9988

Board Members Memberships*

Director
1980-N/A
Former Director
2003-Present
Co-Founder, Chairman of Scientific Advisory Board, Director and Member of Compensation Committee

Education*

PhD
Vanderbilt University
MA
University of Colorado–Boulder
BA
University of Colorado–Boulder
Post-Doctoral Training
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options26,250
Unexercisable Options21,250
Total Number of Options47,500

Total Compensation*

Total Annual Cash Compensation$25,000
Total Calculated Compensation$333,441
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XLRN:US $40.50 USD +1.70

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCELERON PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.